study identifies new autoantibodies as potential biomarkers for COVID-19 severity

The article about autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity is published. In this new study of 246 individuals the IgG autoantibodies against 14 different GPCRs were detected with CellTrend kits. The production of these autoantibodies is deregulated in COVID-19. Patients with moderate and severe disease have higher levels of autoantibodies than…

CellTrend donates for refugees from Ukraine

We also support the people from Ukraine affected by the war with a donation to the Evangelisches Jugend- und Fürsorgewerk! The EJF mobilizes numerous own locations for the accommodation of people fleeing from the war in Ukraine. Donations are e. g. needed, to equip the facilities with new furniture, hygiene articles and children’s toys. You…

weekly POTS, CFS/ME, CRPS, SFN diagnostic

Due to the high demand, POTS, CFS/ME, CRPS, SFN diagnostics are currently carried out weekly. Your submitted sample will therefore be processed within one week. Please send us your sample with the completed request form (important: email address and signature). For guide of blood preparation, please click here! Thanks in advance!      

successful certification audit again

After a successful certification audit at TÜV Rheinland in December 2020, we have now received the new DIN EN ISO 13485:2016 certificate. This means that we are now optimally prepared for the IVDR and have made the change to a certifier that will continue to be approved as a Notified Body for in vitro diagnostics…